Drug Profile
Sitostanol ester - Raisio Group/McNeil Consumer Healthcare
Alternative Names: Benecol; Stanol esterLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Raisio
- Developer McNeil Consumer Healthcare; Raisio
- Class Antihyperlipidaemics; Phytostanols
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Hypercholesterolaemia; Nutrition disorders
Most Recent Events
- 22 Jun 2001 Launched for Hypercholesterolaemia in Denmark (PO)
- 22 Jun 2001 Launched for Hypercholesterolaemia in Ireland (PO)
- 22 Jun 2001 Launched for Hypercholesterolaemia in Sweden (PO)